Trial Profile
A phase 2 proof-of-concept study of SENS-300 in patients with cancer being treated by cisplatin
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 25 Aug 2015
Price :
$35
*
At a glance
- Drugs SENS 300 (Primary)
- Indications Cancer
- Focus Proof of concept; Therapeutic Use
- 25 Aug 2015 New trial record